A groundbreaking research project into a rare type of bone cancer has been launched thanks to Hannah’s Willberry Wonder Pony Charity.
The charity, founded by eventer Hannah Francis who died two years ago from osteosarcoma aged 18, has awarded £230,000 to the University of Sheffield’s department of oncology and metabolism for research into the disease.
The grant will be spent on research in the hope of identifying new drugs that can be used either alone or in combination with chemotherapy to treat osteosarcoma.
Allie Gartland, professor of bone and cancer biology at the department, will be leading the research.
“Osteosarcoma is a particularly nasty disease which has very poor survival rates,” said Professor Gartland.
“Unfortunately, not all patients respond to chemotherapy – their tumours become chemo-resistant and their overall five-year survival rate is then drastically reduced.
“It is shocking to think that treatment for this particularly aggressive form of bone cancer hasn’t changed in the past 30 years.
Horse & Hound Newsletter
Never miss out on the latest happenings in the equestrian world
“There is clearly a need to understand the mechanisms by which chemo-resistance develops so we can find more effective treatments.”
The disease affects about 160 people in the UK each year, of which 30 are children, and attracts very little funding because of its rarity.
This means that there has been limited research conducted in this area and treatment for the disease has not improved in the last 30 years.
“Our aim is to identify drugs that are currently used to treat other diseases, which may also be a more effective way to treat osteosarcoma – whether on their own or in combination with the current chemotherapy strategy,” added Professor Gartland.
In addition to the grant, the charity is also funding two PhD researchers to investigate why osteosarcoma cells become resistant to chemotherapy.
Hannah Francis’ legacy is ‘stronger than ever’ as Willberry donations smash through the £1million barrier
Miles Toulson-Clarke, from the charity, added: “During Hannah’s illness, we contacted Professor Claire Lewis at the University of Sheffield to discuss her innovative ‘Trojan Horse’ research.
“Although there was sadly no opportunity for Hannah to benefit from this, we kept in contact with Professor Lewis and a meeting followed with her and Professor Gartland where the idea of the grant arose.
“Osteosarcoma can strike anyone, but many of the patients are young. The outlook is bleak and the condition causes immense physical pain, never mind the mental burden it imposes on the patient and those close to them.
“It became very evident to us during Hannah’s illness that more research was critical if progress was to be made.
“With her typical focus on others rather than herself, Hannah’s over-riding ambition was to ensure that patients diagnosed with osteosarcoma didn’t have to endure the horrific treatment regime she went through and, critically, that hope could be provided in the future. We’re immensely grateful to our tens of thousands of supporters for making this possible and this is just the beginning of our research funding.”
For all the latest news analysis, competition reports, interviews, features and much more, don’t miss Horse & Hound magazine, on sale every Thursday
Stay in touch with all the news in the run-up to and throughout the major shows and events during 2026 and beyond with a Horse & Hound subscription. Subscribe today for all you need to know ahead of these major events, plus online reports on the action as it happens from our expert team of reporters and in-depth analysis in our special commemorative magazines. Have a subscription already? Set up your unlimited website access now
Lucy is an experienced news journalist, reporter and presenter. Since joining the Horse & Hound team in 2015, Lucy has reported from major global sporting events including the Tokyo Paralympic Games and multiple European Championships, as well as Badminton, Burghley and London, to name a few. She has covered current affairs and sports news across the full spectrum of equestrian disciplines and racing, as well as human and equine welfare, industry news and court cases.
